STOCK TITAN

Alignment Healthcare (ALHC) Stock News

ALHC Nasdaq

Welcome to our dedicated page for Alignment Healthcare news (Ticker: ALHC), a resource for investors and traders seeking the latest updates and insights on Alignment Healthcare stock.

Alignment Healthcare, Inc. reports developments tied to its Medicare Advantage business for seniors, including health plan membership, revenue growth, adjusted gross profit, adjusted EBITDA and annual guidance. The company operates under the Alignment Health consumer brand and works with local provider partners to deliver coordinated care through a customized care model, a 24/7 concierge care team and the AVA® technology platform.

Recurring updates include quarterly and full-year results, membership outlooks for HMO and PPO contracts, Medicare Advantage operating trends, investor conference presentations and registered offerings involving common stock. News also follows the company's expansion of health plan offerings and national footprint within senior care.

Rhea-AI Summary

Alignment Healthcare (NASDAQ: ALHC) announced several leadership changes to support long-term growth and shareholder value.

Founder and CEO John Kao becomes Chairman while remaining CEO. Joseph Konowiecki becomes Vice Chairman and EVP of Corporate Affairs, and the company appoints Mark Kent as MSO President and Shane Hochradel as COO.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Alignment Healthcare (NASD: ALHC) will join the S&P SmallCap 600 effective before trading opens on May 14, 2026, replacing Sun Country Airlines Holdings (NASD: SNCY). The change follows Allegiant Travel (NASD: ALGT) agreeing to acquire Sun Country, pending final closing conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.11%
Tags
none
-
Rhea-AI Summary

Alignment Healthcare (NASDAQ: ALHC) reported Q1 2026 results for the quarter ended March 31, 2026, with $1.235B revenue (up 33.3% YoY) and ~284,800 members (up 30.9% YoY). Adjusted gross profit was $145.9M and adjusted EBITDA was $37.9M (3.1% margin). The company raised midpoints of guidance for membership, revenue, adjusted gross profit and adjusted EBITDA for Q2 and FY2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.12%
Tags
Rhea-AI Summary

Alignment Healthcare (NASDAQ: ALHC) will release its first quarter 2026 financial results on Thursday, April 30, 2026, after market close. Following the release, the company will host a conference call at 5:00 p.m. EDT the same day.

A live audio webcast will be available at the company investor site and via the provided media-server link, with a replay accessible for approximately 12 months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.33%
Tags
conferences earnings date
-
Rhea-AI Summary

Alignment Healthcare (NASDAQ: ALHC) will present at the BofA Securities Health Care Conference 2026 in Las Vegas on Wednesday, May 13, 2026 at 8:40 a.m. PDT. A live webcast and on‑demand replay will be available on Alignment Healthcare’s investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.31%
Tags
none
-
Rhea-AI Summary

Alignment Healthcare (NASDAQ: ALHC) announced the pricing of a secondary offering of 13,167,733 common shares by an affiliate of General Atlantic at a public offering price of $19.46 per share. The Company will not receive proceeds from the sale.

The offering is expected to close on March 4, 2026, subject to customary closing conditions, with J.P. Morgan acting as underwriter. The offering is being made under a Form S-3 shelf registration that became effective on March 2, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.11%
Tags
Rhea-AI Summary

Alignment Healthcare (NASDAQ: ALHC) announced an underwritten public offering on March 2, 2026, of 13,167,733 shares of common stock by an affiliate of General Atlantic, L.P.

The company will not receive any proceeds; J.P. Morgan is acting as underwriter and the offering is made under a Form S-3 shelf registration that became effective March 2, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.11%
Tags
-
Rhea-AI Summary

Alignment Healthcare (NASDAQ: ALHC) reported strong fourth-quarter and full‑year 2025 results, with full‑year revenue of $3.95B (+46.1% YoY) and Q4 revenue of $1,012.8M (+44.4% YoY). Health plan membership ended Q4 at ~236,300 (+25% YoY).

The company posted full‑year adjusted EBITDA of $109.9M and net loss of $1.0M, and raised 2026 guidance to revenue $5.14B–$5.19B (30%–31% growth) and adjusted EBITDA $133M–$163M.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.88%
Tags
none
-
Rhea-AI Summary

Alignment Healthcare (NASDAQ: ALHC) will present at the Leerink Partners Global Healthcare Conference in Miami on Tuesday, March 10, 2026 at 3:40 p.m. EST. A live webcast and on-demand replay will be available on Alignment’s investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.4%
Tags
none
Rhea-AI Summary

Alignment Healthcare (NASDAQ: ALHC) will release fourth-quarter and full-year 2025 financial results on Thursday, Feb. 26, 2026 after market close, followed by a conference call at 5:00 p.m. EST. A live audio webcast will be available and a replay will remain online for approximately 12 months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.84%
Tags
conferences earnings date

FAQ

What is the current stock price of Alignment Healthcare (ALHC)?

The current stock price of Alignment Healthcare (ALHC) is $18.38 as of May 12, 2026.

What is the market cap of Alignment Healthcare (ALHC)?

The market cap of Alignment Healthcare (ALHC) is approximately 3.5B.